Table 2.

Effects of N-FBRT and FBRT on serum fibrosis biomarkers and hepatic hydroxyproline content of rats with liver fibrosis (mean ± SD, n = 8).

Groups	HA/(ng/mL)	LN/(ng/mL)	PC-III/(ng/mL)	C-IV/(ng/mL)	Hyp/(ng/g)
Control	78.35 ± 14.93	45.31 ± 2.98	23.00 ± 4.66	94.07 ± 12.23	36.06 ± 6.36
CCl4	183.00 ± 29.05**	75.67 ± 8.28**	51.00 ± 9.14**	256.16 ± 26.90**	132.54 ± 11.47**
N-FBRT1	108.75 ± 17.02##	52.04 ± 4.07##	31.25 ± 6.29##	123.95 ± 21.84##	39.40 ± 12.07##
N-FBRT2	123.00 ± 27.08#	45.95 ± 2.95##	38.00 ± 13.88	132.84 ± 22.71##	66.84 ± 26.04##
N-FBRT3	137.50 ± 28.79	55.56 ± 6.10#	40.85 ± 7.56	144.50 ± 10.69##	70.94 ± 15.60##
N-FBRT4	147.00 ± 17.39	61.59 ± 5.91	43.00 ± 8.6	143.92 ± 19.77##	97.30 ± 39.80
FBRT	113.35 ± 22.35##	47.60 ± 4.54##	34.85 ± 4.91#	122.87 ± 22.21##	66.87 ± 14.21##
Colchicine	107.50 ± 18.44##	44.59 ± 7.37##	32.15 ± 5.15##	115.37 ± 27.57##	47.93 ± 23.71##

^**P < 0.01 vs control group; ^#P < 0.05, ^##P < 0.01 vs CCl₄ model group.